Lilly demands docs stop selling copycat weight-loss drugs

By Bloomberg
| August 15, 2024

The cease-and-desist letters went to scores of telehealth companies, wellness centers and medical spas, and several brick-and-mortar clinics.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...